Elsa, I did a little more research. There is only one study at RettSyndrome.org, other than Anavex, that includes treating a 22 year old and that’s sponsored by Newron. That study, though, seeks to treat daytime breathing problems. More likely than not, Anavex is the drug helping Hanna get into the SUV seemingly effortlessly.
And the video comes at a time well into the extension of the PK study, where dosing is being titrated.
Why did the leading Rett researcher, who’s expertise is behavior in Rett girls, join Anavex in January?
IMO because he believed 273 could change behavior in Rett girls; and the video sure is strong circumstantial evidence!